A. Jubert

Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.

J. Díez-Domingo, A. Ballester, M. San-Martín, 2004, The Journal of infection.

Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents

J. Poolman, J. Findlow, R. Borrow, 2006, Clinical and Vaccine Immunology.

[Epidemiology and burden of acute otitis media in Valencia (Spain)].

M. Garcés-Sánchez, J. Díez-Domingo, J. Villarroya, 2004, Anales de pediatria.

Seroprevalence of Varicella Among Children and Adolescents in Valencia, Spain: Reliability of the Parent’s Reported History and the Medical File for Identification of Potential Candidates for Vaccination

J. Díez-Domingo, A. Ballester, M. San-Martín, 2005, Human vaccines.

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years: A Phase II, Randomized, Open, Controlled Study

P. Moris, M. Garcés-Sánchez, P. García-Corbeira, 2010, The Pediatric infectious disease journal.

Ibuprofen prophylaxis for adverse reactions to diphtheria-tetanus-pertussis vaccination: a randomized trial

J. Díez-Domingo, A. Ballester, J. Baldó, 1998 .